The World Health Organization celebrates World Mental Health Day today, October 10. In response, Filipinos should learn how ...
As drugs continue to wreak havoc on Queensland communities, we unmask the traffickers who have faced court this year for ...
While the recent spate of positive regulatory updates boosts Bristol Myers, we will advise a wait-and-watch strategy.
The FDA's approval of Bristol Myers Squibb's Cobenfy for schizophrenia opens doors for Reviva's brilaroxazine, a ...
Bristol-Myers’ newly approved schizophrenia treatment might be coming full circle.
Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...
For instance, medications that help with the psychological effects of schizophrenia might also help with schizoid personality disorder. Stimulants, which are medications that energize people, and ...
Nearly 24 million people around the world live with a schizophrenic disorder, making up about 0.32% of the population.
The agency will offer earlier meetings with drugmakers as well as solicit more patient feedback on the process.
The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride) for the treatment of adults with schizophrenia.
The US Food and Drug Administration (FDA) has approved a drug for schizophrenia that is exciting the field with an entirely ...